The regular consumption of very small doses of psychedelic drugs is known as microdosing. 

 

This paper examined subjective experiences of microdosing psychedelics to improve mental health or to cease or reduce substance use, and examined sociodemographic and other covariates of perceived improvements in mental health that individuals attributed to microdosing.

​

This paper focuses on 1102 respondents who reported current or past experience of psychedelic microdosing.

​

Twenty-one percent of respondents reported primarily microdosing as a therapy for depression, 7% for anxiety, 9% for other mental disorders and 2% for substance use cessation or reduction.

 

Forty-four percent of respondents perceived that their mental health was "much better" as a consequence of microdosing.

 

In a multivariate analysis, perceived improvements in mental health from microdosing were associated with a range of variables including gender, education, microdosing duration and motivations, and recent use of larger psychedelic doses.